Granted Patent
B2
US 7,524,868 · App. 11/169,155 · Granted Apr 28, 2009
Substituted pyrazoline compounds, their preparation and use as medicaments
Assignee:
Laboratorios Del Dr. Esteve, S.A.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to substituted pyrazoline compounds, methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.
Claims (3)
1. N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H -pyrazole-3-carboxamide.
2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.
3. A method for the treatment of a food intake disorder comprising administering the compound of claim 1 wherein the disorder is selected from the group consisting of bulimia, anorexia, cachexia, obesity and type II diabetes mellitus.
Assignments (4)
CHANGE OF NAME
Recorded May 7, 2019
From: LABORATORIOS DR. ESTEVE S.A.
To: ESTEVE PHARMACEUTICALS, S.A.
Reel/Frame 049107/0670 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED ON REEL 017818 FRAME 0478. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Recorded May 3, 2019
From: SAEZ, SERGIO ERILL
To: LABORATORIOS DR. ESTEVE S.A.
Reel/Frame 049081/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 20, 2006
From: ERILL SAEZ, SERGIO
To: LABORATORIOS DR. ESTEVE
Reel/Frame 017818/0478 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 11, 2005
From: ALTISEN, ROSA CUBERES; CONSTANSA, JORDI FRIGOLA; SILVA, BONIFACIO GUTIERREZ
To: LABORATORIOS DR. ESTEVE S.A.
Reel/Frame 016632/0258 →
Priority Claims (1)
ES 200400378
· Feb 17, 2004
· national
Continuity (2)
Continuation In Part
1080453400
· Mar 19, 2004